This OSF paper summarises elements of a growing consensus among international bodies on what constitutes good practice in drug prevention programmes. It also assesses some of the challenges of drawing lessons from the existing body of published work on the subject.
The discussion was grouped around five broad areas: demand reduction; supply reduction; new challenges; alternative development; and human rights. Out of the discussions as a whole, some key issues emerged as likely to be central to UNGASS 2016.
According to Harm Reduction International, introducing human rights-based indicators is the only way to ensure that drug policy works to promote the health and welfare of humankind by respecting, protecting and fulfilling international human rights obligations.
West African countries provided their inputs towards the contribution of Member States to the outcome document of the UN General Assembly Special Session.
To defend their drug policy, countries frequently do little more than publicize long lists of achievements, and the UNGASS 2016 is an opportunity to change these metrics of success.
This report summarises the topics discussed and lists the organisations present during the Western European Civil Society Regional Consultation Event in preparation to the UNGASS 2016.
Este relatório do OEDT partilha as experiências existentes com o medicamento a fim de alargar a atual base de conhecimento necessária para a tomada de decisões e para melhorar as respostas de tratamento em situações de emergência.
